




EFFICACY	   OF	   A	   NOVEL	   METHOD	   FOR	   INSPIRATORY	   MUSCLE	   TRAINING	   IN	   CHRONIC	  
OBSTRUCTIVE	  PULMONARY	  DISEASE.	  
D.	   Langer1,2,	   N.	   Charususin1,2,	   C.	   Jacome3,	   M.	   Hoffman4,	  A.	   McConnell5,	  M.	   Decramer2,	   and	  	  
R	  Gosselink1,2.	  
1	  KU	  Leuven	  Faculty	  of	  Kinesiology	  and	  Rehabilitation	  Sciences,	  Leuven,	  Belgium.	  	  
2	  Respiratory	  Rehabilitation	  and	  Respiratory	  Division,	  University	  Hospital	  Leuven,	  Belgium.	  	  
3	  Department	  of	  Physiotherapy,	  Universidade	  de	  Aveiro,	  Aveiro,	  Portugal.	  
4	  Department	  of	  Physiotherapy,	  Universidade	  Federal	  de	  Minas	  Gerais,	  Belo	  Horizonte,	  Brazil	  
5	  Centre	  for	  Sports	  Medicine	  &	  Human	  Performance,	  Brunel	  University,	  London,	  UK.	  
Running	  Head:	  A	  Novel	  Method	  for	  IMT	  in	  COPD	  
Keywords:	   Respiratory	   muscle	   training,	   Respiratory	   muscle	   strength,	   Respiratory	   muscle	  
endurance,	  Tapered	  Flow	  Resistive	  Loading.	  
Correspondence	  to:	  	  
Prof.	  Rik	  Gosselink	  
KU	  Leuven,	  Tervuursevest	  101,	  3001	  Leuven,	  Belgium	  
tel:	  32-­‐16329000,	  fax:	  32-­‐16329196	  
E-­‐mail:	  rik.gosselink@faber.kuleuven.be	  
	  









Background:	  Most	   inspiratory	  muscle	  training	  (IMT)	   interventions	   in	  patients	  with	  COPD	  have	  2	  
been	   implemented	   as	   fully	   supervised	   daily	   training	   for	   30	   minutes	   with	   controlled	   training	  3	  
loads	  using	  mechanical	   threshold	   loading	   (MTL)	  devices.	  Recently,	   an	  electronic	   tapered	   flow	  4	  
resistive	   loading	   (TFRL)	   device	  was	   introduced	   that	   has	   a	   different	   loading	   profile	   and	   stores	  5	  
training	  data	  during	  IMT	  sessions.	  	  6	  
Objective:	   We	   aimed	   to	   compare	   the	   effectiveness	   of	   a	   brief,	   largely	   unsupervised	   IMT	  7	  
protocol,	   conducted	   using	   either	   traditional	   MTL	   or	   TFRL	   on	   inspiratory	   muscle	   function	   in	  8	  
patients	  with	  COPD.	  	  9	  
Design:	  Twenty	   clinically	   stable	   patients	  with	   inspiratory	  muscle	  weakness,	   participating	   in	   a	  10	  
pulmonary	  rehabilitation	  program,	  were	  randomly	  allocated	  to	  perform	  eight	  weeks	  of	  either	  11	  
MTL-­‐	  or	  TFRL-­‐IMT.	  	  12	  
Methods:	  Patients	  performed	  two	  daily	  home-­‐based	   IMT	  sessions	  of	  30	  breaths	   (3-­‐5	  minutes	  13	  
per	  session)	  at	  the	  highest	  tolerable	  intensity,	  supported	  by	  twice	  weekly	  supervised	  sessions.	  14	  
Compliance,	  progression	  of	  training	  intensity,	  increases	  in	  maximal	  inspiratory	  mouth	  pressure	  15	  
(Pi,max)	  and	  endurance	  capacity	  of	  inspiratory	  muscles	  (T,lim)	  were	  evaluated.	  	  16	  
Results:	   More	   than	   90%	   of	   IMT	   sessions	   were	   completed	   in	   both	   groups.	   The	   TFRL	   group	  17	  





effort	  scores	  on	  a	  Borg	  CR-­‐10	  scale,	  and	  achieved	  larger	  improvements	  in	  Pi,max	  (p=0.02),	  and	  1	  
T,lim	  (p=0.02)	  than	  the	  MTL-­‐group.	  	  2	  
Limitation:	  Absence	  of	  a	  study	  arm	  involving	  a	  sham-­‐IMT	  intervention.	  	  3	  
Conclusion:	  The	  short	  and	  largely	  home-­‐based	  IMT	  protocol	  was	  effective	  in	  both	  groups	  and	  is	  4	  
an	   alternative	   to	   traditional	   IMT	   protocols	   in	   this	   population.	   Patients	   in	   the	   TFRL-­‐group	  5	  
tolerated	   higher	   training	   loads	   and	   achieved	   larger	   improvements	   in	   inspiratory	   muscle	  6	  
function	  than	  patients	  in	  the	  MTL	  group.	  	  7	  






Inspiratory	  muscle	  training	  (IMT)	  has	  frequently	  been	  applied	  in	  patients	  with	  COPD	  to	  improve	  2	  
inspiratory	  muscle	   function,	   exertional	   dyspnea,	   and	   exercise	   tolerance.	   Results	   of	   the	   latest	  3	  
meta-­‐analysis	   indicate	   that	   IMT	   as	   a	   standalone	   treatment	   yields	   clinically	   meaningful	  4	  
improvements	   in	   inspiratory	   muscle	   strength	   and	   endurance,	   functional	   exercise	   capacity,	  5	  
dyspnea,	   and	   quality	   of	   life.1	   Studies	   included	   in	   the	   meta-­‐analysis	   implemented	   fully	  6	  
supervised	   training	   protocols	   with	   controlled	   training	   loads,	   and	   mostly	   consisted	   of	   daily	  7	  
training	   with	   mechanical	   threshold	   loading	   (MTL)	   devices	   for	   about	   30	   minutes.1	   To	   our	  8	  
knowledge	   only	   a	   single	   shorter	   (42	   minutes	   of	   weekly	   training	   in	   comparison	   to	   150-­‐210	  9	  
minutes),	  but	   still	   fully	   supervised	   IMT	  protocol	   	  has	  previously	  been	  studied	   in	  patients	  with	  10	  
COPD.2;3	  This	  shorter	  IMT	  protocol	  resulted	  in	  improvements	  in	  inspiratory	  muscle	  function	  that	  11	  
were	  comparable	  to	  longer	  programs.4-­‐6	  There	  is	  currently	  a	  scarcity	  of	  research	  relating	  to	  the	  12	  
efficacy	  of	  short	  and	  largely	  unsupervised	  (home-­‐based)	  IMT	  programs	  in	  patients	  with	  COPD.	  13	  
The	   latest	   systematic	   review1	  was	   further	  accompanied	  by	  an	  editorial	   that	  questioned	   the	  14	  
role	  for	  inspiratory	  muscle	  training	  in	  the	  comprehensive	  rehabilitative	  treatment	  for	  patients	  15	  
with	  COPD	  with	  the	  main	  argument	  that	  time	  spent	  supervising	  patients	  during	  IMT	  sessions	  16	  
should	   rather	  be	   spent	  offering	   them	  general	   exercise	   training	   since	   this	   is	  would	  be	  more	  17	  
beneficial	  for	  patients.7	  	  18	  
Recently,	   an	   electronic	   IMT	   device	   was	   introduced	   (POWERbreathe®	   KH1,	   HaB	   International	  19	  





Another	  novel	   feature	  of	   the	  electronic	   IMT	  device	   is	   that	   flow	  and	  pressure	  data	  are	   stored	  1	  
continuously	   during	   IMT	   sessions,	   permitting	   objective	   monitoring	   of	   home-­‐based	   IMT	  2	  
programs	   from	   a	   distance.	   We	   hypothesized	   that	   this	   feature	   would	   reduce	   the	   amount	   of	  3	  
supervision	  needed	  for	  a	  short	  IMT	  program	  to	  be	  effective.	  Large	  differences	  that	  have	  been	  4	  
observed	   in	   response	   to	   previous	   training	   interventions	   that	   were	   not	   performed	   fully	  5	  
supervised	  might	  have	  partly	  been	  due	  to	  insufficient	  compliance	  to	  the	  training	  intervention.	  6	  
This	   could	   however	   so	   far	   not	   be	   reliably	   assessed.	   This	   is	   why	   we	   believed	   that	   an	  7	  
intervention	  that	  has	  the	  potential	  to	  reduce	  weekly	  training	  time	  and	  time	  spent	  supervising	  8	  
patients	   (by	   electronically	   controlling	   training	   compliance)	   would	   be	   worthy	   of	   further	  9	  
exploration.	  10	  
We	  further	  hypothesized	  that	  TFRL	  would	  enable	  higher	  intensities	  of	  IMT	  to	  be	  tolerated	  than	  11	  
MTL.	  Gradual	  reduction	  of	  the	  absolute	  load	  during	  inhalation	  against	  the	  TFRL	  accommodates	  12	  
the	   pressure-­‐volume	   relationship	   of	   the	   inspiratory	   muscles	   and	   thereby	   helps	   to	   maintain	  13	  
resistance	  at	  the	  same	  relative	  intensity	  throughout	  inhalation.	  This	  theoretically	  should	  enable	  14	  
patients	  to	  tolerate	  higher	  training	  intensities	  (see	  methods	  section	  for	  more	  detail).	  	  15	  
The	   aims	   of	   the	   current	   study	  were	   therefore	   1)	   to	   assess	   the	   effectiveness	   of	   a	   short	   and	  16	  
largely	  home-­‐based	  IMT	  program;	  and	  2)	  to	  find	  out	  whether	  performing	  and	  monitoring	  this	  17	  
program	   with	   an	   electronic	   TFRL	   device	   would	   enable	   patients	   to	   reach	   higher	   training	  18	  
intensities	  and	  achieve	   larger	   improvements	   in	   inspiratory	  muscle	  function	  than	  after	  training	  19	  






The	   study	   was	   approved	   by	   the	   University	   Hospital	   Leuven’s	   Institutional	   Review	   Board	  2	  
(Approval	  Number	  ML7489).	  Interventions	  started	  after	  patients	  gave	  written	  informed	  consent	  3	  
and	  outcomes	  were	  evaluated	   after	   8	  weeks.	   Clinically	   stable	  COPD	  patients	  with	   inspiratory	  4	  
muscle	  weakness	  (maximal	  inspiratory	  mouth	  pressure	  (Pi,max)	  <100%	  of	  the	  predicted	  normal	  5	  
value)	   who	   were	   participating	   in	   a	   multidisciplinary	   pulmonary	   rehabilitation	   program	   were	  6	  
eligible	  for	  participation	  in	  the	  study.	  Patients	  were	  eligible	  to	  participate	  in	  the	  rehabilitation	  7	  
program	  if	  they	  1)	  were	  younger	  than	  75	  years	  of	  age;	  2)	  had	  a	  forced	  expiratory	  volume	  in	  1	  8	  
second	  (FEV1)	  that	  was	  less	  than	  65%	  of	  the	  predicted	  value;	  and	  3)	  if	  their	  clinical	  condition	  9	  
was	   stable	   at	   inclusion,	   with	   no	   infection	   or	   COPD	   exacerbation	   in	   the	   previous	   4	   weeks.	  10	  
Exclusion	  criteria	  consisted	  of	  1)	  diagnosed	  psychiatric	  or	  cognitive	  disorders;	  2)	  progressive	  11	  
neurological	   or	   neuromuscular	   disorders;	   3)	   severe	   orthopaedic	   problems	   having	   a	   major	  12	  
impact	   on	   daily	   activities;	   4)	   previous	   inclusion	   in	   rehabilitation	   program	   (<1	   year);	   and	   5)	  13	  
severely	   reduced	  maximal	   inspiratory	  mouth	  pressures	   (Pi,max<60cmH2O).	  The	   latter	  group	  14	  
of	  patients	  with	  severe	  weakness	  was	  not	  eligible	  since	  they	  were	  included	  into	  an	  ongoing	  15	  
multicenter-­‐trial.9	   Allocation	   concealment	   was	   ensured	   by	   using	   a	   previously	   described	  16	  
method	  to	  assign	  patients	  randomly	  to	  either	  MTL	  or	  TFRL-­‐IMT,	  using	  sequentially	  numbered,	  17	  
opaque	  sealed	  envelopes.10	  18	  
Training	  method.	   In	  analogy	   to	   training	  protocols	   that	  have	   frequently	  and	  successfully	  been	  19	  





(Threshold®,	   Philips	   Respironics,	   Brussels,	   Belgium	   or	   POWERbreathe®	   Medic,	   HaB	  1	  
International	   Ltd.,	   Southam,	   UK)	   or	   TFRL-­‐IMT	   (POWERbreathe®	   KH1,	   HaB	   International	   Ltd.,	  2	  
Southam,	   UK)	   at	   the	   highest	   tolerable	   intensity.	   Since	   the	   highest	   resistance	   that	   the	  3	  
Threshold®	   trainer	   can	   provide	   is	   41	   cmH2O,	   the	   POWERbreathe®	   Medic	   device	   (maximal	  4	  
resistance	  of	  up	  to	  90cmH2O)	  was	  used	  in	  patients	  who	  were	  able	  to	  tolerate	  higher	  training	  5	  
intensities.	  An	  example	  of	  a	  supervised	  TFRL-­‐IMT	  session	   is	  provided	   in	  a	  supplemental	  video	  6	  
clip.	   Differences	   in	   the	   characteristics	   of	   the	   applied	   inspiratory	   resistances	   between	   devices	  7	  
are	   summarized	   in	   Figure	  1.	  Methods	  used	   to	  obtain	   these	  data	   from	  both	   the	  MTL	  and	   the	  8	  
TFRL	   device	   using	   continuous	   registrations	   of	   flow	   and	   pressure	   with	   external,	   laboratory	  9	  
measurement	   equipment	   have	   previously	   been	   reported.8	   Figure	   1	   illustrates	   a	   comparison	  10	  
between	  a	  single	  inhalation	  undertaken	  by	  the	  same	  patient	  during	  either	  mechanical	  pressure	  11	  
threshold	   loading	  (MTL	  -­‐	   left	  panel)	  or	   tapered	  flow	  resistive	   loading	  (TFRL	  -­‐	   right	  panel).	  The	  12	  
TFRL	  device	  applies	  a	  tapered	  resistance	  provided	  by	  an	  electronically	  controlled,	  dynamically	  13	  
adjusted	   valve,	   which	   contrasts	   to	   the	   constant	   load	   applied	   by	   the	  MTL	   device.	   After	   flow-­‐14	  
independently	   overcoming	   an	   initial	   threshold	   load	   (in	   this	   case	   50	   cmH2O	   corresponding	   to	  15	  
60%	   of	   subjects	   Pi,max	   on	   both	   devices)	   pressure	   remains	   constant	   during	  MTL	   (left	   panel),	  16	  
whereas	  during	  TFRL,	  pressure	   is	  volume-­‐dependently	  tapered	  during	   inhalation	  (right	  panel).	  17	  
This	   reduction	   of	   the	   absolute	   load	   during	   inhalation	   against	   the	   TFRL	   accommodates	   the	  18	  
pressure-­‐volume	   relationship	   of	   the	   inspiratory	   muscles	   and	   thereby	   helps	   to	   maintain	  19	  





load	   allows	   end-­‐inspiratory	   volume	   to	   approach	   total	   lung	   capacity,	   even	   at	   high	   training	  1	  
intensities.	   It	   is	   apparent	   from	   the	   example	   shown	   in	   Figure	   1	   that	   this	   patient	   with	   COPD,	  2	  
training	   at	   60%	   of	   his	   Pi,max,	   was	   able	   to	   achieve	   an	   inspiratory	   volume	   during	   TFRL	   (right	  3	  
panel)	   that	  was	   twice	   that	   achieved	  during	  MTL	   (left	  panel).	   Furthermore,	  due	   to	   this	  higher	  4	  
inspiratory	   tidal	   volume,	  more	   external	  work	  was	   performed	  per	   breath	   (see	   Figure	   1,	   AUC),	  5	  
despite	   of	   a	   lower	   mean	   inspiratory	   pressure	   during	   inhalation.	   These	   observations	   confirm	  6	  
limitations	  to	  the	  intensity	  of	  pressure	  threshold	  loading	  that	  were	  recently	  identified	  in	  healthy	  7	  
people.13	   In	   this	   study,	   the	   authors	   found	   that	   the	   amount	   of	   external	   mechanical	   work	  8	  
undertaken	  during	   loading	  >60%	  of	  Pi,max	  decreased	  considerably	  due	  to	   impairment	  of	  tidal	  9	  
volume	  expansions	  and	  premature	  termination	  of	   inhalation.13	   In	  this	  way	  high	   intensity	  TFRL	  10	  
(in	  contrast	  to	  MTL)	  provides	  a	  training	  stimulus	  to	  the	   inspiratory	  muscles	  at	  shorter	   lengths	  11	  
which	  corresponds	  to	  operating	  lengths	  of	  these	  muscles	  during	  exercise	  (especially	  in	  patients	  12	  
with	  COPD	  who	  dynamically	  hyperinflate).	  	  13	  
The	   tapered	   flow	   resistive	   loading	   (TFRL)	   approach	   is	   novel	   and	   developed	   specifically	   to	  14	  
overcome	  the	  limitations	  of	  previous	  inspiratory	  flow	  resistive	  loading	  (IFRL)	  techniques	  and	  15	  
devices	   (Pflex,	   DHD-­‐IMT	   and	   TIRE).14-­‐16	   The	   inherent	   limitation	   of	   traditional	   non-­‐targeted	  16	  
IFRL	  devices	   is	   that	   inspiratory	  pressure	   (i.e.	   training	   load)	  varies	  with	   inspiratory	   flow	   (the	  17	  
slower	  the	  inspiratory	  flow,	  the	  smaller	  the	  resistive	  load)	  and	  not	  only	  with	  orifice	  size	  (the	  18	  
smaller	  the	  orifice,	  the	  greater	  the	  resistive	  load).	  Whilst	  this	  specific	  limitation	  is	  overcome	  19	  





their	  own	  limitations.	  The	  Test	  of	  Incremental	  Respiratory	  Endurance	  (TIRE;	  RT2	  and	  Trainair)	  1	  
overcomes	   the	   primary	   limitation	   of	   IFRL	   by	   setting	   inspiratory	   pressure	   relative	   to	   a	  2	  
participant’s	   Pi,max,	   and	   by	   providing	   biofeedback	   via	   a	   target	   template.	   However	   the	  3	  
functional	  relevance	  of	  the	  approach	  is	  questionable,	  since	  each	  breath	  manoeuvre	  requires	  a	  4	  
full	   inspiratory	   inhalation	   through	   a	   very	   small	   inspiratory	   orifice	   (comparable	   to	   the	  5	  
inspiratory	   valve	   leak	   of	   a	   mouth	   pressure	  meter),	   resulting	   in	   unphysiological	   inspiratory	  6	  
flow	  (inspiratory	  time	  can	  exceed	  20	  seconds);	  the	  method	  is	  also	  time	  consuming,	  and	  very	  7	  
demanding	   for	   the	   patient.	   The	  main	   limitation	   of	   the	   target	   flow	   IMT	   (e.g.	   combining	   an	  8	  
incentive	   spirometer	   with	   DHD-­‐IMT)	   is	   that	   there	   is	   no	   monitoring	   or	   control	   of	   inspired	  9	  
volume,	  which	  is	  a	  crucial	  determinant	  of	  inspiratory	  work.13	  10	  
All	   of	   these	   limitations	   are	   overcome	   with	   the	   TFRL	   device.	   The	   valve	   in	   the	   TFRL	   device	  11	  
adjusts	   dynamically	   (100	   times	   per	   second),	   in	   real-­‐time	   to	   accommodate	   within	   breath	  12	  
changes	   in	   inspiratory	   flow	   rate.	   These	   adjustments	   maintain	   the	   pressure	   load	   that	   is	  13	  
delivered	   to	   the	   inspiratory	   muscles	   at	   the	   same	   relative	   intensity	   (percentage	   of	   Pi,max)	  14	  
across	   the	  vital	   capacity.	   It	   is	  a	  dynamic	  adjustment	   to	  a	  prescribed	   target,	  not	   the	  passive	  15	  
decrease	   in	   pressure	   that	   occurs	   in	   response	   to	   decreasing	   inspired	   flow	   rate	   with	   IFRL.	  16	  
Moreover,	  TFRL	  also	  incorporates	  an	  initial	  threshold	  load	  that	  must	  be	  overcome	  before	  the	  17	  
flow	  dependent,	  dynamical	  adjustments	  to	  the	  resistive	  load	  come	  into	  play.	  18	  
Perhaps	  more	   importantly,	   TFRL	   also	   facilitates	   simultaneous	   high	   pressure	   and	   	   high	   flow	  19	  





Pi,max	  are	  about	  2	  seconds;	  see	  also	  supplementary	  video,	  Table	  2	  and	  previously	  published	  1	  
data8).	   Tidal	   volume	   is	   unconstrained	   by	   functional	   weakening	   of	   the	   inspiratory	  muscles,	  2	  
because	   the	   load	   tapers	   during	   inhalation,	   thereby	   permitting	   full	   use	   of	   the	   inspiratory	  3	  
capacity,	  maintenance	   of	  maximal	   inspiratory	   flow	   rate,	   and	  maximized	   inspiratory	  muscle	  4	  
work	  and	  power.	   Patients	  with	  expiratory	   flow	   limitation	   (EFL)	  must	  overcome	  high	  elastic	  5	  
and	  resistive	  loads	  (due	  to	  EFL	  and	  acute-­‐on-­‐chronic	  dynamic	  hyperinflation)	  during	  exercise,	  6	  
whilst	   simultaneously	  being	   forced	   to	  generate	  high	   inspiratory	   flow	  rates	  (high	   inspiratory	  7	  
work	   and	  power)	   to	  meet	   their	   increasing	   ventilatory	   needs.	   Further	   functional	  weakening	  8	  
occurs	  by	  being	  forced	  to	  operate	  at	  shorter	  lengths	  due	  to	  increases	  in	  end-­‐expiratory	  lung	  9	  
volume.	  The	  loading	  characteristics	  delivered	  by	  TFRL	  are	  optimized	  to	  these	  demands	  and	  it	  10	  
is	   hypothesized	   that	   the	   resulting	   training	   stimulus	   will	   prepare	   the	   inspiratory	   muscles	  11	  
better	  for	  these	  specific	  task	  requirements.	  12	  
A	   further	   advantage	   of	   the	   TFRL	   device	   over	   previously	   used	  MTL	   devices	   (especially	   during	  13	  
unsupervised	   training	   programs)	   might	   be	   the	   ability	   to	   store	   parameters	   of	   up	   to	   38	   IMT	  14	  
sessions.	  Continuous	   registrations	  of	  pressure	  and	   flow	   (500Hz)	  provide	  data	  on	   the	  external	  15	  
work	   of	   breathing	   and	   allow	   control	   of	   both	   quantity	   and	   quality	   of	   unsupervised	   training	  16	  
sessions.	   The	   device	   reliably	   stores	   data	   on	   average	  mean	   pressure	   (cmH2O),	   average	  mean	  17	  
power	   per	   breath	   (Watt),	   average	   peak	   flow	   per	   breath	   (L/s)	   and	   total	   external	   	  mechanical	  18	  





Two	   weekly	   IMT	   sessions	   in	   both	   the	   TFRL-­‐	   and	   the	   MTL-­‐	   group	   were	   performed	   under	  1	  
supervision	  of	  a	  physiotherapist	  and	  all	  other	  sessions	  were	  performed	  by	  the	  patients	  at	  home,	  2	  
without	  supervision.	  Patients	  had	  to	  wear	  nose	  clips	  during	  all	  IMT	  sessions.	  Both	  groups	  were	  3	  
instructed	  to	  perform	  fast	  and	  forceful	  inspirations	  and	  were	  encouraged	  to	  achieve	  maximal	  4	  
inhalation	  and	  exhalation	  with	  every	  breath	  (start	  inhaling	  from	  residual	  volume	  and	  to	  finish	  5	  
their	  breath	  as	  close	  to	  total	   lung	  capacity	  as	  possible).	  The	  main	  aim	  of	  this	  training	  method	  6	  
was	   to	   increase	   inspiratory	  muscle	  power	  output	  by	   improving	  both	   strength	   and	   velocity	   of	  7	  
contractions	  over	  the	  full	  range	  of	  motion.	  We	  aimed	  to	   initiate	  IMT	  at	  a	  minimum	  of	  40%	  of	  8	  
baseline	  Pi,max	  (assessed	  from	  residual	  volume).	  In	  both	  groups	  inspiratory	  load	  was	  increased	  9	  
during	  each	  supervised	  session	  to	  the	  highest	  tolerable	  intensity	  at	  that	  moment.	  Intermediate	  10	  
measurements	  of	  Pi,max	  were	  performed	  once	  weekly.	  The	  a	  priori	  aim	  in	  both	  groups	  was	  to	  11	  
increase	  training	  loads	  during	  the	  program	  to	  equal	  at	  least	  50%	  of	  the	  patients’	  actual	  Pi,max	  12	  
in	   every	   week.	   Rates	   of	   perceived	   inspiratory	   effort	   on	   a	  modified	   CR-­‐10	   Borg	   Scale,17	   	   and	  13	  
subjective	  impressions	  of	  physiotherapists	  during	  supervised	  sessions,	  were	  taken	  into	  account	  14	  
to	  determine	   the	  highest	   tolerable	   load	   for	  each	   individual	  patient.	  Respiratory	  effort	   scores	  15	  
between	   4	   and	   6	   were	   aimed	   at	   to	   stimulate	   patients	   to	   train	   at	   the	   highest	   tolerable	  16	  
intensity.	  Compliance	  with	  the	  IMT	  protocol	  was	  assessed	  by	  a	  written	  training	  diary	  in	  the	  MTL	  17	  
group	   and	   by	   analyzing	   objectively	   registered,	   and	   automatically	   stored	   training	   session	  18	  
parameters	   (pressure,	   flow,	   power,	   and	  work)	   in	   the	   TFRL	   group.	   Physiotherapists	   compared	  19	  





based	   sessions	   to	  elicit	   full	   effort	  during	  unsupervised	   IMT.	  This	  was	  not	  possible	   in	   the	  MTL	  1	  
group.	  2	  
Measurements.	   Primary	   (Pi,max	  and	   inspiratory	  muscle	  endurance)	   and	   secondary	  endpoints	  3	  
(changes	  in	  breathing	  pattern	  during	  the	  inspiratory	  muscle	  endurance	  task)	  were	  assessed	  by	  4	  
experienced	  investigators	  who	  were	  not	  involved	  with	  the	  IMT	  sessions	  and	  thereby	  blinded	  to	  5	  
group	  allocation.	  The	  physiotherapists	  who	  provided	  the	  IMT	  sessions	  to	  the	  patients	  in	  both	  6	  
groups	  were	  not	  blinded	  to	  the	  intervention.	  7	  
Inspiratory	  muscle	   strength.	  Pi,max	  was	   recorded	   at	   the	  mouth	   as	   a	   surrogate	   of	   inspiratory	  8	  
muscle	   force.	   Measurements	   were	   performed	   from	   residual	   volume	   using	   the	   technique	  9	  
proposed	   by	   Black	   and	   Hyatt.18	   An	   electronic	   pressure	   transducer	   was	   used	   (MicroRPM;	  10	  
Micromedical,	   Kent,	   UK).	   Assessments	   were	   performed	   on	   two	   separate	   days	   and	   were	  11	  
repeated	  at	   least	  5	   times	  on	  each	  occasion	  until	   the	   three	  best	  measurements	  differed	   from	  12	  
each	  other	  by	  less	  than	  5cmH2O.	  Reference	  values	  published	  by	  Rochester	  and	  Arora	  were	  used	  13	  
to	  define	  normal	  respiratory	  muscle	  force.19	  14	  
Inspiratory	  muscle	  endurance.	  Patients	  were	  asked	  to	  breathe	  against	  a	  sub	  maximal	  inspiratory	  15	  
load	  provided	  by	  the	  TFRL	  device	  (POWERbreathe®	  KH1,	  HaB	  International	  Ltd.,	  Southam,	  UK)	  16	  
until	  task	  failure	  due	  to	  symptom	  limitation	  (T,lim).	  At	  baseline	  an	  inspiratory	  load	  was	  selected	  17	  
that	  allowed	  patients	  to	  continue	  breathing	  for	  3-­‐7	  minutes.	  After	  an	  initial	  familiarization	  trial	  18	  
at	   40%	   Pi,max	   the	   load	   was	   either	   increased	   or	   decreased	   for	   the	   next	   test	   based	   on	   the	  19	  





same	  day	  to	  determine	  a	  load	  that	  would	  allow	  patients	  to	  continue	  breathing	  for	  3-­‐7	  minutes.	  1	  
On	  a	  separate	  day	  the	  test	  was	  repeated	  at	  least	  once	  against	  the	  established	  load	  and	  the	  best	  2	  
result	  was	  recorded	  as	  the	  baseline	  T,lim.	  Breathing	   instructions	  were	  the	  same	  as	  during	  the	  3	  
training	   sessions.	   Number	   of	   breaths,	   average	   inspiratory	   time	   (Ti)	   as	   a	   fraction	   of	   the	   total	  4	  
respiratory	  cycle	  duration	  (Ttot),	  average	  mean	  load,	  average	  mean	  power,	  and	  total	  external	  5	  
inspiratory	  work	  were	  derived	  from	  continuous	  measurements	  of	  flow	  and	  pressure	  during	  the	  6	  
test	   and	   recorded	   by	   the	   previously	   validated	   electronic	   loading	   device.8	   Simultaneous	  7	  
continuous	  measurements	  of	  flow	  and	  pressure	  were	  also	  performed	  with	  external,	  laboratory	  8	  
measurement	  equipment	  according	  to	  methods	  previously	  described.8	  After	  8	  weeks	  of	  IMT	  the	  9	  
endurance	   test	  was	   repeated	   using	   an	   identical	   load.	   Improvements	   in	   T,lim	   and	   changes	   in	  10	  
breathing	  parameters	  were	  recorded	  as	  main	  outcomes.	  A	  limit	  of	  15	  minutes	  was	  handled	  as	  11	  
the	  maximum	  duration	  of	  the	  test	  performed	  after	  8	  weeks.	  In	  case	  patients	  were	  not	  symptom	  12	  
limited	  at	  this	  time	  point	  the	  assessor	  stopped	  the	  test.	  13	  
Pulmonary	   function.	  Spirometry	  and	  whole	  body	  plethysmography	  were	  performed	  according	  14	  
to	   international	   guidelines	   for	   pulmonary	   function	   testing	   (Vmax	   Autobox,	   Sensor	   Medics,	  15	  
Bilthoven,	  the	  Netherlands).20;21	  16	  
Statistical	   Analysis.	   In	   the	   absence	   of	   an	   established	  minimal	   clinically	   important	   difference,	  17	  
the	   sample	   size	   calculation	  was	  based	  on	   a	  Pi,max	  effect	   size	  of	   1.41	   that	  was	   reported	   in	   a	  18	  
study	   by	   Belman	   and	   colleagues	   on	   the	   effects	   of	   high-­‐intensity	   vs.	   low-­‐intensity	   targeted	  19	  





of	   80%	   and	   risk	   for	   type	   I	   error	   (α)	   <	   5%	   a	   sample	   size	   of	   7	   patients	   for	   each	   group	   was	  1	  
calculated.	  Taking	  an	  expected	  drop-­‐out	   rate	  of	  30%	   into	  account	  we	   included	  10	  patients	   in	  2	  
each	   group. Differences	   between	   the	   MTL	   and	   the	   TFRL	   group	   after	   the	   intervention	   were	  3	  
compared,	  adjusting	  for	  baseline	  differences,	  in	  an	  analysis	  of	  covariance	  (ANCOVA).23	  The	  idea	  4	  
behind	  using	  analysis	  of	  covariance	  is	  that	  a	  correction	  is	  made	  for	  regression	  to	  the	  mean.24	  5	  
Regression	  to	  the	  mean	  at	  follow-­‐up	  is	  expected	  to	  occur	  when	  the	  mean	  baseline	  values	  of	  6	  
the	   intervention	   and	   control	   group	   differ.	   Correction	   for	   regression	   to	   the	   mean	   using	  7	  
analysis	   of	   covariance	  was	   achieved	   in	   our	   analysis	   by	   addition	   of	   the	   baseline	   value	   as	   a	  8	  
covariate	  in	  an	  analysis	  in	  which	  the	  follow-­‐up	  measurement	  was	  the	  outcome	  variable	  and	  9	  
group	  allocation	  was	  the	  independent	  variable.	  Not	  correcting	  for	  baseline	  differences	  in	  this	  10	  
way	  has	  been	  shown	  to	  lead	  to	  either	  over-­‐	  or	  underestimation	  of	  the	  estimated	  intervention	  11	  
effect.25	  12	  
Two-­‐Way	   ANOVA	   using	   post-­‐hoc	   tests	   with	   Bonferroni	   corrections	   on	   a	   group	   x	   time	  13	  
interaction	  were	  performed	   to	   compare	   tolerated	   training	   intensities	  between	  groups.	   This	  14	  
was	  done	  to	  investigate	  whether	  the	  group	  (TFRL	  or	  MTL)	  had	  the	  same	  influence	  on	  training	  15	  







Twenty	   patients	   were	   selected	   and	   randomized	   between	   January	   and	   December	   2012	   (10	  2	  
patients	  in	  the	  TFRL	  group	  and	  10	  patients	  in	  the	  MTL	  group).	  A	  diagram	  summarizing	  the	  flow	  3	  
through	  the	  study	  is	  presented	  in	  Figure	  2.	  All	  patients	  who	  were	  recruited	  for	  this	  study	  were	  4	  
categorized	   in	   spirometric	   GOLD	   stages	   II	   and	   III.	   After	   8	   weeks	   of	   IMT	   outcomes	   from	   10	  5	  
patients	  in	  the	  TFRL	  and	  9	  patients	  in	  the	  MTL	  group	  were	  analyzed.	  One	  patient	  from	  the	  MTL	  6	  
group	  dropped	  out	  of	  the	  study	  during	  the	  final	  week	  of	  the	  intervention	  after	  a	  hospitalization	  7	  
due	  to	  an	  acute	  exacerbation.	  Baseline	  characteristics	  of	  participants	  are	  presented	  in	  Table	  1.	  8	  
Groups	   were	   well	   matched	   for	   gender,	   age,	   inspiratory	   muscle	   function	   and	   pulmonary	  9	  
function.	  Patients	  in	  the	  TFRL	  group	  had	  a	  normal	  average	  weight,	  whereas	  patients	  from	  the	  10	  
MTL	  group	  were	  on	  average	  overweight.	  Patients	  in	  both	  groups	  had	  comparable	  impairment	  11	  
of	  baseline	  Pi,max.	  T,lim	  and	  relative	  intensity	  (%Pi,max)	  of	  the	  endurance	  breathing	  task	  were	  12	  
also	  comparable	  between	  groups	  (Table	  1).	  	  13	  
Training	   Progression.	   In	   the	   TFRL	   group	   95±7%	   of	   sessions	   (based	   on	   data	   stored	   by	   the	  14	  
electronic	   device)	   and	   93±6%	  of	   the	   sessions	   in	   the	  MTL	   group	   (based	   on	   data	   from	  written	  15	  
patient	  diaries)	  were	  completed.	  Duration	  of	  the	  supervised	  training	  sessions	  ranged	  from	  3	  to	  16	  
5	   minutes	   corresponding	   to	   a	   daily	   training	   duration	   for	   both	   groups	   ranging	   from	   6	   to	   10	  17	  
minutes.	  Progression	  of	  training	  intensity	  in	  both	  groups	  is	  illustrated	  in	  Figure	  3.	  Patients	  in	  the	  18	  
TFRL	  group	  increased	  their	  training	  load	  from	  45±8%	  of	  their	  baseline	  Pi,max,	  in	  the	  first	  week	  19	  





load	   from	   38±11%	  of	   their	   baseline	   Pi,max	   value,	   to	   61±19%	   (p<0.001).	   Patients	   in	   the	   TFRL	  1	  
group	  tolerated	  a	  significantly	  higher	  training	  load	  during	  the	  final	  three	  weeks	  of	  the	  training	  2	  
protocol	   (all	   p	   <0.05;	   Figure	   2).	   Despite	   the	   differing	   training	   intensities,	   average	  Borg	   CR-­‐10	  3	  
scores	  at	  the	  end	  of	  the	  supervised	  training	  sessions	  were	  similar	  for	  the	  TFRL	  group	  and	  MTL	  4	  
group	  for	  perceived	  inspiratory	  effort	  (3.0±1.6	  vs.	  3.6±1.1,	  respectively;	  p=0.35)	  and	  perceived	  5	  
dyspnea	  (2.3±0.6	  vs.	  2.0±0.2,	  respectively;	  p=0.70).	  6	  
Pulmonary	  function.	  There	  were	  no	  significant	  improvements	  in	  pulmonary	  function	  in	  either	  7	  
of	   the	   two	   groups	   (both	   within	   group	   p>0.05)	   and	   also	   no	   differences	   in	   improvements	  8	  
between	   groups	   (FEV1%pred:	   3±7	   vs.	   4±9,	   p=0.662;	   FVC%pred:	   4±9	   vs.	   9±16,	   p=0.495;	   and	  9	  
FRC%pred:	  -­‐14±22	  vs.	  -­‐10±20,	  p=0.714).	  10	  
Inspiratory	  Muscle	  Strength.	  Both	  groups	  exhibited	   significant	   improvements	   in	  Pi,max	   (both	  11	  
within	   group	   p<0.01),	   but	   patients	   in	   the	   TFRL	   group	   showed	   a	   significantly	   larger	   increase	  12	  
(TFRL	   31±4	   cmH2O,	   67±17	   to	   99±16	   cmH2O	   vs.	   MTL	   18±6	   cmH2O,	   70±14	   to	   89±26	   cmH2O;	  13	  
p=0.02).	  	  14	  
Inspiratory	   Muscle	   Endurance.	   Changes	   in	   breathing	   parameters	   during	   the	   endurance	  15	  
breathing	  task	  are	  summarized	  in	  Table	  2.	  Increases	  in	  T,lim,	  number	  of	  breaths	  and	  total	  work	  16	  
were	   significantly	   higher	   in	   the	   TFRL	   group.	   Patients	   in	   this	   group	  were	   also	   able	   to	   achieve	  17	  
larger	   increases	   in	   their	   peak	   inspiratory	   flow	   during	   the	   loaded	   breathing	   task,	   indicating	  18	  
enhanced	  velocity	  of	  shortening	  of	  the	  inspiratory	  muscles	  under	  load.	  This	  resulted	  in	   larger,	  19	  





the	   duty	   cycle	   in	   the	   TFRL	   group.	   Increases	   in	   average	   inspiratory	   volume	   and	   average	  work	  1	  







Discussion	  	  1	  
We	  studied	  the	  effects	  of	  a	  short	  and	  largely	  home-­‐based	  IMT	  program	  in	  patients	  with	  COPD.	  2	  
Patients	   were	   compliant	   with	   the	   IMT	   protocol	   and	   achieved	   significant	   improvements	   in	  3	  
inspiratory	  muscle	   strength	   and	  endurance.	   Patients	   in	   the	  TFRL	   group	   tolerated	   significantly	  4	  
higher	   training	   loads,	   as	   well	   as	   achieving	   significantly	   larger	   and	   more	   comprehensive	  5	  
improvements	   in	   inspiratory	   muscle	   function	   (i.e.	   strength,	   power,	   shortening	   velocity,	   and	  6	  
endurance)	  than	  patients	  in	  the	  MTL	  group.	  7	  
Effectiveness	   of	   the	   novel	   training	  method	   in	   comparison	  with	   previous	   IMT	  protocols.	  The	  8	  
average	  improvements	  in	  Pi,max	  of	  18cmH2O	  (MTL)	  and	  31cmH2O	  (TFRL)	  after	  8	  weeks	  of	  IMT	  9	  
in	   the	   current	   study	   both	   exceeded	   the	   average	   increase	   in	   Pi,max	   of	   13cmH2O	   that	   was	  10	  
reported	   in	   the	   latest	   meta-­‐analysis	   of	   randomised	   controlled	   trials	   of	   standalone	   IMT.1	  11	  
Furthermore,	  the	  average	  increase	  in	  breathing	  endurance	  time	  reported	  in	  this	  meta-­‐analysis	  12	  
(261	  seconds)	  was	  exceeded	  in	  the	  TFRL	  group	  (532	  seconds)	  and	  was	  approached	  in	  the	  MTL	  13	  
group	  (187	  seconds).1	  These	  data	  are	  encouraging,	  since	  all	  RCTs	  included	  in	  the	  meta-­‐analysis	  14	  
implemented	   fully	   supervised	   training	   protocols	  with	   daily	   training	   durations	   of	   30	  minutes.1	  15	  
Our	   IMT	   protocol	   was	   largely	   home-­‐based	   and	   consisted	   of	   only	   two	   daily	   sessions	   of	   30	  16	  
breaths	   (~6-­‐10	   minutes)	   of	   daily	   training.	   Despite	   of	   this	   short	   daily	   training	   duration	   the	  17	  
program	  resulted	  not	  only	   in	   improved	  strength	  but	  also	   improved	  endurance	  capacity	  of	  the	  18	  
inspiratory	  muscles.	   Improvements	   in	   Pi,max	   of	   25%	   (MTL)	   and	   45%	   (TFRL)	   after	   this	   home-­‐19	  





shorter	   training	   durations	   (29%	   to	   32%	   increases	   in	   Pi,max	   with	   42	   minutes	   of	   weekly	  1	  
training).2;3	  This	  short	  protocol	  also	  resulted	  in	  improved	  endurance	  capacity.26	  These	  short	  IMT	  2	  
protocols	   are	   similar	   to	   those	   that	   have	   been	   applied	   successfully	   in	   healthy	   subjects.11	   The	  3	  
current	  findings	  support	  the	  feasibility	  and	  efficacy	  of	  a	  brief,	  intense,	  and	  largely	  home-­‐based	  4	  
IMT	   protocol	   in	   patients	   with	   COPD	   and	   demonstrate	   that	   this	   protocol	   seems	   to	   be	   most	  5	  
effective	  when	  carried	  out	  and	  supervised	  with	  an	  electronic	  TFRL	  device.	  Reductions	   in	   time	  6	  
investment	   in	   comparison	   to	   previous	   protocols	   might	   help	   to	   improve	   both	   adherence	   of	  7	  
patients	   and	   to	   increase	   motivation	   of	   health	   care	   providers	   to	   prescribe	   and	   provide	   the	  8	  
intervention.	  	  9	  
Comparing	   effects	   of	  MTL-­‐	   and	   TFRL-­‐IMT.	   One	   factor	   that	  might	   have	   contributed	   to	   better	  10	  
outcomes	  in	  the	  TFRL	  group	  during	  this	  home-­‐based	  IMT	  program	  was	  the	  ability	  to	  objectively	  11	  
monitor	  unsupervised	  training	  sessions.	   In	  contrast	  to	  the	  TFRL	  group,	  monitoring	  of	  the	  MTL	  12	  
group	  completely	  relied	  on	  self-­‐reported	  data	  of	  completed	  IMT	  sessions,	  which	  did	  not	  allow	  13	  
us	   to	   control	   the	   quality	   of	   the	   unsupervised	   sessions	   and	   may	   also	   have	   over-­‐estimated	  14	  
training	   compliance.	   Another	   explanation	   for	   the	   larger	   improvements	   of	   inspiratory	  muscle	  15	  
function	  in	  the	  TFRL	  group	  might	  have	  been	  related	  to	  the	  differences	  in	  the	  applied	  loads	  (see	  16	  
methods).	   Inspiratory	   effort	   reported	   by	   patients	   at	   the	   end	   of	   supervised	   IMT	   sessions	  was	  17	  
comparable	   between	   the	   MTL	   and	   the	   TFRL	   group,	   which	   confirms	   that	   both	   groups	   were	  18	  





Changes	   in	   breathing	   pattern	   characteristics	   during	   loaded	   breathing.	   We	   observed	  1	  
significantly	   larger	   increases	   in	   inspiratory	   flow	  during	   the	   loaded	   breathing	   task	   in	   the	   TFRL	  2	  
group,	   which	   resulted	   in	   larger	   increases	   in	   inspiratory	   power	   output	   and	   reductions	   in	  3	  
inspiratory	   time.	   Significant	   enhancement	   in	   the	   velocity	   of	   inspiratory	   muscle	   shortening	  4	  
during	  resistive	  breathing	  tasks,	  and	  increases	  in	  the	  size	  of	  type	  2	  muscle	  fibers	  following	  MTL-­‐5	  
IMT	  have	  been	  observed	  previously	  in	  patients	  with	  COPD.6;27	  These	  improvements	  might	  be	  of	  6	  
clinical	   relevance	   to	   patients	   since	   they	   should	   prepare	   them	   for	   the	   requirements	   that	  7	  
increasing	  ventilatory	  needs	  impose	  on	  their	  inspiratory	  muscles	  during	  physical	  activity.	  During	  8	  
exercise	   in	  COPD	  functional	  weakening	  of	   inspiratory	  muscles	  occurs	  when	  they	  are	  forced	  to	  9	  
contract	   at	   shorter	   lengths	   (high	   lung	   volumes)	   and	   higher	   velocities	   (shortened	   time	   for	  10	  
inspiration).	   At	   the	   same	   time	   these	   muscles	   face	   increasingly	   higher	   elastic	   loads	   during	  11	  
exercise	  due	  to	  progressive	  dynamic	  hyperinflation.	  This	  results	  in	  an	  increase	  in	  motor	  drive	  to	  12	  
the	   inspiratory	   muscles	   that	   is	   associated	   with	   an	   increased	   sense	   of	   respiratory	   effort	   and	  13	  
dyspnea.28;29	  Further	  studies	  are	  warranted	  to	  explore	  whether	  the	  improvements	  in	  inspiratory	  14	  
muscle	  power	  characteristics	  with	  TFRL-­‐IMT	  can	  help	  to	  reduce	  efferent	  drive	  to	  these	  muscles	  15	  
and	  improve	  the	  perception	  of	  respiratory	  effort	  and	  dyspnea	  during	  exercise.	  16	  
Limitations.	  A	  valid	  concern	  is	  that	  we	  were	  assessing	  the	  efficacy	  of	  our	  interventions	  against	  17	  
the	   background	   of	   improvements	   due	   to	   simultaneous	   exercise	   training.	   A	   limitation	   of	   this	  18	  
study	   is	   therefore	   the	   absence	   of	   a	   control	   group	   performing	   a	   pulmonary	   rehabilitation	  19	  





both	   of	   our	   interventions	   exceed	   improvements	   in	   Pi,max	   of	   11cmH2O	   that	   were	   reported	  1	  
previously	   after	   a	   similar,	   but	   longer,	   pulmonary	   rehabilitation	   program	   without	   additional	  2	  
IMT.31	   We	   further	   focused	   exclusively	   on	   measurements	   of	   inspiratory	   muscle	   function	   and	  3	  
found	  significantly	   larger	   improvements	   in	  the	  TFRL	  group,	  which	   is	  suggesting	  a	  true	  training	  4	  
effect.	   Our	   study	   was	   not	   designed	   and	   sufficiently	   powered	   to	   investigate	   whether	   this	  5	  
additional	   improvement	   in	   inspiratory	   muscle	   function	   yielded	   greater	   changes	   in	   exercise	  6	  
capacity	  and	  quality	  of	  life.	  A	  large,	  adequately	  powered	  RCT	  examining	  the	  effects	  of	  IMT	  as	  an	  7	  
adjunct	   to	   pulmonary	   rehabilitation	   on	   functional	   exercise	   capacity	   and	   quality	   of	   life	   is	  8	  
currently	  addressing	  this	  question.9	  Another	  shortcoming	  is	  that	  improvements	  in	  Pi,max	  were	  9	  
only	   assessed	   from	   residual	   volume,	   and	   not	   from	   FRC,	   or	   higher	   volumes	   that	   are	   more	  10	  
representative	   of	   operating	   lung	   volumes	   during	   rest	   and	   exercise	   in	   these	   patients.	   Length	  11	  
specificity	  of	   inspiratory	  muscle	   training	  has	  been	  demonstrated	  previously,32	  and	   it	  might	  be	  12	  
that	  TFRL	  has	  a	  larger	  effect	  on	  pressure	  generating	  capacities	  of	  inspiratory	  muscles	  at	  shorter	  13	  
muscle	   lengths	   (i.e.	   higher	   lung	   volumes)	   than	   MTL-­‐IMT	   which	   should	   be	   further	   studied.	  14	  
Finally,	   the	  endurance	  breathing	   task	  was	  only	  performed	  against	   TFRL	  and	  not	  against	  MTL.	  15	  
Larger	   improvements	   in	   endurance	   capacity	   and	   more	   pronounced	   changes	   in	   breathing	  16	  
pattern	  in	  the	  TFRL	  group	  might	  therefore	  have	  been	  related	  to	  the	  higher	  task	  specificity	  of	  the	  17	  
test.	   Based	   on	   the	   current	   data	   it	   is	   unclear	   whether	   the	   observed	   changes	   in	   breathing	  18	  





to	  less	  specific	  tasks	  such	  as	  breathing	  during	  exercise	  or	  breathing	  against	  a	  different	  type	  of	  1	  
inspiratory	  resistance.	  This	  should	  be	  investigated	  in	  future	  studies.	  2	  
Conclusions	  3	  
The	  presented	  IMT	  method	  required	  less	  time	  investment	  from	  both	  health	  care	  providers	  and	  4	  
patients	  and	  resulted	  in	  significant	  improvements	  in	  inspiratory	  muscle	  function	  in	  comparison	  5	  
with	  previously	  described	  fully	  supervised	  IMT	  interventions	  in	  patients	  with	  COPD.	  The	  largely	  6	  
home-­‐based	   program	  was	  most	   efficient	  when	   performed	   and	   supervised	  with	   an	   electronic	  7	  
TFRL	   device.	   Patients	   in	   the	   TFRL	   group	   tolerated	   higher	   training	   intensities	   and	   achieved	  8	  
significantly	   larger	   improvements	   in	   inspiratory	   muscle	   function	   than	   patients	   using	  9	  
conventional	   MTL	   devices	   for	   the	   same	   perceived	   effort.	   Costs	   and	   effectiveness	   of	   the	  10	  
different	   approaches	   need	   to	   be	   weighed	   against	   each	   other	   when	   implementing	   the	  11	  
intervention	   in	   clinical	   practice.	   Further	   research	   should	   be	   directed	   towards	   assessing	   the	  12	  
effects	  of	  this	  novel	  IMT	  method	  on	  inspiratory	  muscle	  function	  and	  dyspnea	  perception	  during	  13	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TFRL	  (n=10)	   MTL	  (n=10)	  
Sex	  (F/M)	   5/5	   5/5	  
Age	  (years)	   64±5	   67±8	  
BMI	  (Kg/m2)	   22.6±6.6	   27.7±6.0	  
Pi,max	  (cmH2O)	   	  	  67±17	   	  	  70±19	  
Pi,max	  (%pred.)	   67±10	   71±15	  
T,lim	  (sec)	   219±71	   	  	  208±139	  
Intensity	  Endurance	  test	  
(%Pi,max)	  
50±11	   50±13	  
FEV1	  (%pred.)	   60±17	   54±15	  
FVC	  (%pred.)	   91±16	   79±22	  
FRC	  (%pred.)	   132±35	   138±36	  
	  
Table	  1	  Legend:	  TFRL	  =	  tapered	  flow	  resistive	  loading;	  MTL	  =	  mechanical	  threshold	  loading;	  F	  =	  
female;	  M	  =	  male;	  BMI	  =	  Body	  Mass	  Index;	  Pi,max	  =	  maximal	  inspiratory	  pressure;	  T,lim	  =	  time	  
that	  patients	  could	  sustain	  the	  endurance	  breathing	  task	  until	  symptom	  limitation;	  FEV1	  =	  
forced	  expiratory	  volume	  in	  one	  second;	  FVC	  =	  forced	  vital	  capacity;	  FRC	  =	  functional	  residual	  










Table	  2:	  Changes	  in	  breathing	  characteristics	  during	  the	  inspiratory	  muscle	  endurance	  task.	  	  
 TFRL	  (n=10)	   MTL	  (n=9)	  
p-­‐value#	  
 Pre	   Post	   Changes	   Pre	   Post	   Changes	  
Δ	  tlim	  sec	   219±71	   751±168	   +532±204*	   193±124	   361±309	   +187±233*	   0.02	  
Δ	  Breaths	  n	  	   32±12	   95±34	   +64±27*	   32±18	   52±33	   +21±33*	   0.03	  
Δ	  Total	  Work	  J	   132±73	   539±235	   +407±230*	   157±188	   331±466	   +193±245*	   0.03	  
Δ	  Avg.	  Inspiratory	  Time	  
(ti)	  sec	  	  
2.7±1.3	   1.6±0.6	   -­‐1.1±0.8*	   2.3±1.1	   2.0±0.8	   -­‐0.2±0.3	   0.02	  
Δ	  Ti/Ttot	  (duty	  cycle)	  %	  	   37±6	   21±8	   -­‐16±6*	   37±7	   33±11	   -­‐5±5*	   0.02	  
Δ	  Avg.	  Peak	  Inspiratory	  
Flow	  L/sec	  	  
2.1±0.5	   3.4±0.7	   +1.4±0.6*	   1.9±0.5	   1.9±0.8	   +0.1±0.3	   0.001	  
Δ	  Avg.	  Mean	  Power	  per	  
Breath	  Watt	  	  
1.9±0.6	   4.2±1.5	   +2.3±1.0*	   2.0±0.9	   2.5±1.7	   +0.5±1.2	   0.004	  
Δ	  Avg.	  Inspiratory	  
Volume	  L	  	  
1.8±0.7	   2.2±0.6	   +0.4±0.2*	   1.6±0.7	   1.7±1	   +0.1±0.1	   0.25	  
Δ	  Avg.	  Work	  per	  Breath	  J	  	   4.7±3.5	   6.4±3.9	   +1.7±1.0*	   4.6±3.7	   5.3±5.2	   +0.7±1.1	   0.27	  
	  
Table	  2	  Legend:	  TFRL	  =	  tapered	  flow	  resistive	  loading;	  MTL	  =	  mechanical	  threshold	  loading;	  tlim	  
=	  time	  that	  patients	  could	  sustain	  the	  endurance	  breathing	  task;	  Ti	  =	  inspiratory	  time;	  Ttot	  =	  
time	  of	  a	  complete	  respiratory	  cycle;	  *	  indicates	  a	  statistically	  significant	  increase	  from	  baseline	  
to	  8-­‐weeks	  within	  groups	  (p<0.05).	  Changes	  are	  expressed	  as	  differences	  (∆)	  between	  pre	  and	  
post	  values	  and	  presented	  as	  means	  ±	  standard	  deviate	  ons.	  #P-­‐values	  are	  reported	  for	  
between	  group	  comparisons	  (TFRL	  vs	  MTL)	  of	  post-­‐intervention	  values	  with	  baseline	  values	  








Figure	  1:	  Comparison	  between	  two	  training	  devices	  during	  a	  typical	  inhalation	  against	  a	  
resistance	  corresponding	  to	  60%	  of	  baseline	  Pi,max	  (50cmH2O).	  AUC	  =	  Area	  under	  the	  curve	  for	  
total	  external	  inspiratory	  work	  as	  integrated	  from	  mouth	  pressure	  (cmH2O)	  and	  volume	  (L)	  
signals	  over	  time.	  	  
Figure	  2:	  A	  diagram	  summarizing	  the	  flow	  of	  patients	  through	  the	  study.	  
Figure	  3:	  Progression	  of	  training	  intensity	  expressed	  as	  a	  percentage	  of	  baseline	  Pi,max.	  TFRL	  =	  
tapered	  flow	  resistive	  loading;	  MTL	  =	  mechanical	  threshold	  loading.	  *	  =	  p<0.05	  between	  groups.	  






































































































































Video	  1	   Legend:	  Example	  of	   a	   supervised	   inspiratory	  muscle	   training	   session	  performed	  with	  
the	  tapered	  flow	  resistive	  loading	  device	  illustrating	  1)	  the	  selection	  of	  an	  appropriate	  training	  
load;	   2)	   administration	   of	   BORG	   CR-­‐10	   scores	   for	   dyspnea	   and	   inspiratory	   effort	   before	   and	  
after	   the	   training	   session;	   and	  3)	   registration	  of	   training	   session	  data	   (pressure,	   flow,	  power,	  
and	  work)	  that	  are	  stored	  by	  the	  handheld	  training	  device	  in	  a	  personalized	  training	  diary.	  	  
